US20230302047A1 | 28 September 2023 | Application | US18124391 | Trace element compositions, methods of making and use | American Regent Inc |
---|
US20230293714A1 | 21 September 2023 | Application | US18016864 | Combination of anti-her2 antibody-drug conjugate with her dimerization inhibitor | Daiichi Sankyo Co Ltd |
---|
US20230287121A1 | 14 September 2023 | Application | US18318610 | Bispecific antibody | Daiichi Sankyo Co Ltd; Mie University Graduate School of Medicine |
---|
US20230287119A1 | 14 September 2023 | Application | US18194987 | Anti-cd3 antibody and molecules comprising the antibody | Daiichi Sankyo Co Ltd |
---|
US20230277534A1 | 7 September 2023 | Application | US17895972 | Compounds and methods for kinase modulation, and indications therefor | Plexxikon Inc |
---|
US20230203132A1 | 29 June 2023 | Application | US18057480 | Active mmp9-binding peptide | Daiichi Sankyo Co Ltd |
---|
US20230144876A1 | 11 May 2023 | Application | US17907531 | Immune inducer containing polynucleotide-peptide conjugate and pharmaceutical composition containing same | Daiichi Sankyo Co Ltd; The University of Kitakyushu |
---|
US20230139769A1 | 4 May 2023 | Application | US17878611 | Anti-muc1 antibody-drug conjugate | Daiichi Sankyo Co Ltd |
---|
US20230136988A1 | 4 May 2023 | Application | US18046270 | Griseofulvin compound | Daiichi Sankyo Co Ltd |
---|
US20230097700A1 | 30 March 2023 | Application | US17781918 | Azetidine sulfonamide compound | Daiichi Sankyo Co Ltd |
---|